Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Completed NA INTERVENTIONAL NCT02058186

Effect of Oral Vitamin D Supplement on Atopic Dermatitis; A Clinical Trial With Staphylococcus Aureus Colonization Determination

View on ClinicalTrials.gov Updated Dec 15, 2025

Brief Summary

Background: Increase in skin colonization of Staphylococcus aureus (S. aureus) in atopic dermatitis patients (AD) resulted from the reduction of cathelicidin production in these patients plays the important role in pathogenesis of this disease. Recently in vivo study has showed that vitamin D can stimulate cathelicidin production. Oral supplement of vitamin D might be beneficial in atopic dermatitis. Objective: To determine the effect of oral vitamin D supplement on clinical impact including skin colonization of S. aureus in atopic dermatitis patients.

Interventions

Name: oral vitamin D
Type: DRUG
Description:
Name: Placebo
Type: DRUG
Description:

Primary Outcomes

Measure: SCORAD score
TimeFrame: May - August 2012 (3 months)
Description:

Trial Information

NCT ID

NCT02058186

Status

Completed

Study Type

INTERVENTIONAL

Phases

NA

Sponsor

Srinakharinwirot University

Last Updated

December 15, 2025